Enochian

DEADLINE ALERT for MF, YQ, ENOB: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Tuesday, August 23, 2022

BENSALEM, Pa., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • BENSALEM, Pa., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to [email protected] .
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Enochian Biosciences, Inc. (ENOB)

Retrieved on: 
Monday, August 22, 2022

On May 25, 2022, the U.S. Department of Justice announced that Serhat Gumrukcu, the co-founder and inventor of Enochian, had been arrested in a murder-for-hire conspiracy.

Key Points: 
  • On May 25, 2022, the U.S. Department of Justice announced that Serhat Gumrukcu, the co-founder and inventor of Enochian, had been arrested in a murder-for-hire conspiracy.
  • On this news, the Companys shares fell $2.17, or 37%, to close at $3.70 per share on May 25, 2022, on unusually heavy trading volume.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ENOB

Retrieved on: 
Saturday, August 20, 2022

WHAT TO DO NEXT: To join the Enochian BioSciences class action, go to https://rosenlegal.com/submit-form/?case_id=6517 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Enochian BioSciences class action, go to https://rosenlegal.com/submit-form/?case_id=6517 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That Securities Class Action Lawsuits Have Been Filed on Behalf of Investors in Inotiv, Inc. (NOTV), Unity Software, Inc. (U), Enochian Biosciences, Inc. (ENOB) and Encourages Investors to Contact the

Retrieved on: 
Friday, August 19, 2022

Additional information about each case can be found at the links provided below.

Key Points: 
  • Additional information about each case can be found at the links provided below.
  • Kirby McInerney is a New York-based plaintiffs law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.
  • The firms efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline – ENOB

Retrieved on: 
Wednesday, August 17, 2022

NEW YORK, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.

Key Points: 
  • NEW YORK, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

DEADLINE ALERT for MF, YQ, ENOB, and WEBR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Wednesday, August 17, 2022

LOS ANGELES, Aug. 17, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, Aug. 17, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • The Law Offices of Frank R. Cruz, Los Angeles

ENOCHIAN BIOSCIENCES, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against Enochian Bioscience

Retrieved on: 
Tuesday, August 16, 2022

All investors who purchased the shares of Enochian Biosciences, Inc. and incurred losses are advised to contact the firm immediately at [email protected] or (800) 575-0735 or (212) 545-4774.

Key Points: 
  • All investors who purchased the shares of Enochian Biosciences, Inc. and incurred losses are advised to contact the firm immediately at [email protected] or (800) 575-0735 or (212) 545-4774.
  • You may obtain request additional information concerning the action at www.whafh.com .
  • If you have incurred losses in Enochian Biosciences, Inc. you may, no later than September 26, 2022, request that the Court appoint you lead plaintiff of the proposed class.
  • Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country.

DEADLINE ALERT for AMZN, MF, YQ, ENOB: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Tuesday, August 16, 2022

BENSALEM, Pa., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • BENSALEM, Pa., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to [email protected] .
  • Law Offices of Howard G. Smith

Enochian Biosciences Inc. Shareholder Notice: Robbins LLP is Investigating Enochian Biosciences Inc. (ENOB) on Behalf of Shareholders

Retrieved on: 
Tuesday, August 16, 2022

Shareholder rights law firm Robbins LLP is investigating Enochian Biosciences Inc. (NASDAQ: ENOB) and its officers and directors to evaluate whether they violated securities laws or breached fiduciary duties by overstating the Company's commercial prospects for its product pipeline.

Key Points: 
  • Shareholder rights law firm Robbins LLP is investigating Enochian Biosciences Inc. (NASDAQ: ENOB) and its officers and directors to evaluate whether they violated securities laws or breached fiduciary duties by overstating the Company's commercial prospects for its product pipeline.
  • If you would like more information about our investigation of Enochian Biosciences Inc.'s misconduct, click here .
  • On this news, the price of Enochian's stock fell almost 37%, to close at $3.70 per share on May 25, 2022.
  • Next Steps: If you acquired shares of Enochian Biosciences Inc. between September 24, 2020 and May 31, 2022, you have legal rights.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Enochian Biosciences, Inc. (ENOB)

Retrieved on: 
Monday, August 15, 2022

On May 25, 2022, the U.S. Department of Justice announced that Serhat Gumrukcu, the co-founder and inventor of Enochian, had been arrested in a murder-for-hire conspiracy.

Key Points: 
  • On May 25, 2022, the U.S. Department of Justice announced that Serhat Gumrukcu, the co-founder and inventor of Enochian, had been arrested in a murder-for-hire conspiracy.
  • On this news, the Companys shares fell $2.17, or 37%, to close at $3.70 per share on May 25, 2022, on unusually heavy trading volume.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles